Delirium, catatonía y síndrome de abstinencia manifestados como agitación psicomotora en COVID-19: una propuesta de manejo farmacológico en el hospital general / Delirium, catatonia and substance withdrawal syndrome manifested as psychomotor agitation in COVID-19: a pharmacological management approach for the general hospital setting
Rev. méd. Chile
; 150(3): 361-367, mar. 2022. tab, graf
Article
en Es
| LILACS
| ID: biblio-1409809
Biblioteca responsable:
CL126.2
ABSTRACT
BACKGROUND:
Neuropsychiatric symptoms can be part of the clinical spectrum of COVID-19 infections.AIM:
To devise an evidence based clinical algorithm as a guide for clinicians, to identify and treat underlying clinical syndromes of psychomotor agitation, such as delirium, catatonia or substance withdrawal in patients who are hospitalized and infected with SARS-CoV-2. MATERIAL ANDMETHODS:
A review of the literature about the pharmacological management of neuropsychiatric manifestations of COVID-19 at the general hospital, to develop a clinical protocol based on a consensus from an interdisciplinary expert panel at a Clinical Hospital.Results:
A consensual clinical algorithm for the management of delirium, catatonia, and substance withdrawal, manifested as psychomotor agitation in patients hospitalized with COVID-19, was developed as a clinical proposal for physicians at different levels of complexity in health services.CONCLUSIONS:
Cooperation among different clinical units in the general hospital facilitated the implementation of a clinical algorithm for clinicians for the management of psychomotor agitation in COVID-19 patients.Palabras clave
Texto completo:
1
Índice:
LILACS
Asunto principal:
Síndrome de Abstinencia a Sustancias
/
Catatonia
/
Delirio
/
COVID-19
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
Es
Revista:
Rev. méd. Chile
Asunto de la revista:
MEDICINA
Año:
2022
Tipo del documento:
Article